BioMarin Pharmaceutical (BMRN) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
BioMarin Pharmaceutical · Health Care · ref. ETF XLV · 118 calls · price $65.29
What the company does: BioMarin Pharmaceutical Inc. specializes in creating and bringing to market treatments for individuals suffering from severe and often fatal rare disorders and other critical medical conditions.
📈 BioMarin Pharmaceutical (BMRN) stock price
$65.29+13.2% over range
Aug 28, 25low $49.67 · high $70.24Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
85% recommend buying · 13 analysts
📊 JPI status : BioMarin Pharmaceutical has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 BMRN price target & analyst consensus — price $65.29
The price target · all analysts combined (13 targets)
Highest target · 1 firm of 13$124+89.9%
Median target · of 13 targets$97+48.6%
Lowest target · 1 firm of 13$59-9.6%
Current price$65.29
Where these 13 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1185%
$76 ↔ $124
Below
215%
$59 ↔ $62
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: HC Wainwright & Co. — 70% of its targets hit on this sector (238 calls tested). It aims for $59 (-9.6 %), call made on August 19, 2026, maturing on August 19, 2027 (9 d ago).
The 5 reliable analysts
$76+16 %
The 8 other firms
$102+56 %
How to read it: the 5 reliable firms are not filtered by optimism — 3 aim above the price, 2 below, hence their $76 median. “The 8 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 13 ratings (last 6 months)
Strong Buy00%
Buy1185%
Hold215%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 BMRN price target all
All 118 calls, one by one, with our verdict on each firm.
→ See all 118 targets, analyst by analyst💡 The best analysts on BMRN most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in BMRN? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about BioMarin Pharmaceutical? The JPI assistant answers using our backtest data.
📈 BioMarin Pharmaceutical fundamentals: valuation, margins & growth › open the full page
P/E 176.5Net margin 2.1 %Revenue growth +19.9 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 7 %
2023
Rev +15%Profit +18%
2024
Rev +18%Profit +155%
2025
Rev +13%Profit −18%
🔎 Detailed analyses
✅ Historical analyst reliability on BMRN
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Leerink Swann | 100% | +15.2% | 3 |
| Citigroup ↗ | 80% | +35.3% | 5 |
| RBC Capital ↗ | 67% | -7.3% | 3 |
| Credit Suisse | 65% | +16.5% | 17 |
| Canaccord Genuity ↗ | 60% | +5.2% | 10 |
| BMO Capital ↗ | 60% | +0.9% | 5 |
| Deutsche Bank ↗ | 60% | -9.5% | 5 |
| SVB Leerink | 57% | -6.6% | 7 |
| UBS ↗ | 56% | +28.3% | 9 |
| Wedbush ↗ | 50% | -3.5% | 6 |
See the other 19 firms
| Wells Fargo ↗ | 0% | -26.0% | 3 |
| Raymond James ↗ | 0% | -19.8% | 2 |
| Cantor Fitzgerald ↗ | 0% | -18.5% | 15 |
| B of A Securities ↗ | 0% | -17.0% | 5 |
| Nomura | 0% | -16.7% | 2 |
| Oppenheimer ↗ | 0% | -7.6% | 2 |
| Truist Securities ↗ | 17% | -15.5% | 6 |
| Baird ↗ | 25% | -9.7% | 4 |
| JP Morgan ↗ | 25% | -9.6% | 12 |
| Piper Sandler ↗ | 25% | -8.1% | 12 |
| Guggenheim ↗ | 25% | -6.2% | 4 |
| Morgan Stanley ↗ | 29% | -2.4% | 17 |
| Bernstein ↗ | 33% | -17.7% | 3 |
| Evercore ISI Group ↗ | 40% | -10.0% | 5 |
| SunTrust Robinson Humphrey | 40% | -5.1% | 5 |
| Goldman Sachs ↗ | 40% | -1.1% | 5 |
| Barclays ↗ | 42% | -2.6% | 12 |
| Jefferies ↗ | 45% | +6.9% | 11 |
| Stifel ↗ | 47% | -2.6% | 15 |
📊 What $1,000 invested in BioMarin Pharmaceutical would be worth › open the full page
In short — $1,000 invested in BioMarin Pharmaceutical 10 years ago would be worth $546 today, i.e. -6%/yr on average. Best year: 2022 (+17%), worst: 2024 (-32%). Price performance, excluding dividends.
If I'd invested $1,000 in BioMarin Pharmaceutical
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $871 | -13% |
| 3 years ago | $553 | -45% |
| 5 years ago | $653 | -35% |
Return by year (BioMarin Pharmaceutical)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -4% | $963 (-4%) |
| 2025 | -10% | $871 (-13%) |
| 2024 | -32% | $593 (-41%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on BioMarin Pharmaceutical
Loading news…
📋 All analyst calls on BMRN
Filtered on — · ✕ show all
BMO Capital ↗
Aug 19, 26
▲ Outperform · 🎯$98
Price at call : $69.33 — upside +41%
Today : $65.29 — upside +50%
🎯 on BMRN : no call matured yet · 📊 on Health : 45.7% · +6.4% (35 calls)
in progress (365j)
matures : Aug 19, 27
matures : Aug 19, 27
HC Wainwright & Co. ↗
Aug 18, 26
■ Neutral neutral · not a buy · 🎯$59
Price at call : $69.33 — gap to target -15%
Today : $65.29 — gap to target -10%
🎯 on BMRN : no call matured yet · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Aug 18, 27
matures : Aug 18, 27
Piper Sandler ↗
Aug 17, 26
▲ Overweight · 🎯$88
Price at call : $66.99 — upside +31%
Today : $65.29 — upside +35%
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Aug 17, 27
matures : Aug 17, 27
▲ Overweight · 🎯$111
Price at call : $66.64 — upside +67%
Today : $65.29 — upside +70%
🎯 on BMRN : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Aug 17, 27
matures : Aug 17, 27
Canaccord Genuity ↗
Aug 10, 26
▲ Buy · 🎯$114
Price at call : $68.88 — upside +66%
Today : $65.29 — upside +75%
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : Aug 10, 27
matures : Aug 10, 27
Morgan Stanley ↗
Aug 7, 26
▲ Overweight · 🎯$124
Price at call : $68.88 — upside +80%
Today : $65.29 — upside +90%
🎯 on BMRN : 0% (1 call matured) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
Oppenheimer ↗
Aug 7, 26
▲ Outperform · 🎯$97
Price at call : $68.88 — upside +41%
Today : $65.29 — upside +49%
🎯 on BMRN : no call matured yet · 📊 on Health : 53.6% · +4.5% (69 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
HC Wainwright & Co. ↗
Aug 7, 26
■ Neutral neutral · not a buy · 🎯$60
Price at call : $63.81 — gap to target -6%
Today : $65.29 — gap to target -8%
🎯 on BMRN : no call matured yet · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
See the other 110 calls, newest to oldest
▲ Buy · 🎯$76
Price at call : $59.59 — upside +28%
Today : $65.29 — upside +16%
🎯 on BMRN : no call matured yet · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Jul 16, 27
matures : Jul 16, 27
RBC Capital ↗
Jul 7, 26
■ Sector Perform neutral · not a buy · 🎯$62
Price at call : $59.75 — gap to target +4%
Today : $65.29 — gap to target -5%
🎯 on BMRN : no call matured yet · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
Canaccord Genuity ↗
May 22, 26
▲ Buy · 🎯$111
Price at call : $52.88 — upside +110%
Today : $65.29 — upside +70%
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : May 22, 27
matures : May 22, 27
B of A Securities ↗
May 19, 26
▲ Buy · 🎯$80
Price at call : $50.2 — upside +59%
Today : $65.29 — upside +23%
🎯 on BMRN : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : May 19, 27
matures : May 19, 27
▲ Buy · 🎯$75
Price at call : $50.2 — upside +49%
Today : $65.29 — upside +15%
🎯 on BMRN : no call matured yet · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : May 19, 27
matures : May 19, 27
HC Wainwright & Co. ↗
May 18, 26
■ Neutral neutral · not a buy · 🎯$50
Price at call : $49.81 — gap to target +0%
Today : $65.29 — gap to target -23%
🎯 on BMRN : no call matured yet · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
Canaccord Genuity ↗
May 8, 26
▲ Buy · 🎯$116
Price at call : $54.06 — upside +115%
Today : $65.29 — upside +78%
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
▲ Outperform · 🎯$82
Price at call : $54.6 — upside +50%
Today : $65.29 — upside +26%
🎯 on BMRN : 0% (2 calls matureds) · 📊 on Health : 50% · -5.0% (6 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
Morgan Stanley ↗
May 5, 26
▲ Overweight · 🎯$119
Price at call : $54.6 — upside +118%
Today : $65.29 — upside +82%
🎯 on BMRN : 0% (1 call matured) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
RBC Capital ↗
May 5, 26
■ Sector Perform neutral · not a buy · 🎯$66
Price at call : $54.6 — gap to target +21%
Today : $65.29 — gap to target +1%
🎯 on BMRN : no call matured yet · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
Evercore ISI Group ↗
May 5, 26
▲ Outperform · 🎯$120
Price at call : $54.6 — upside +120%
Today : $65.29 — upside +84%
🎯 on BMRN : no call matured yet · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
HC Wainwright & Co. ↗
May 5, 26
■ Neutral neutral · not a buy · 🎯$55
Price at call : $53.24 — gap to target +3%
Today : $65.29 — gap to target -16%
🎯 on BMRN : no call matured yet · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
B of A Securities ↗
Mar 11, 26
▲ Buy · 🎯$85
Price at call : $60.32 — upside +41%
Today : $65.29 — upside +30%
🎯 on BMRN : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Mar 11, 27
matures : Mar 11, 27
▲ Overweight · 🎯$105
Price at call : $60.57 — upside +73%
Today : $65.29 — upside +61%
🎯 on BMRN : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Mar 4, 27
matures : Mar 4, 27
HC Wainwright & Co. ↗
Mar 2, 26
■ Neutral neutral · not a buy · 🎯$55
Price at call : $59.74 — gap to target -8%
Today : $65.29 — gap to target -16%
🎯 on BMRN : no call matured yet · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Mar 2, 27
matures : Mar 2, 27
Freedom Broker
Mar 2, 26
▲ Buy · 🎯$105
Price at call : $59.74 — upside +76%
Today : $65.29 — upside +61%
🎯 on BMRN : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Mar 2, 27
matures : Mar 2, 27
Canaccord Genuity ↗
Feb 26, 26
▲ Buy · 🎯$104
Price at call : $61.73 — upside +68%
Today : $65.29 — upside +59%
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Outperform · 🎯$94
Price at call : $61.11 — upside +54%
Today : $65.29 — upside +44%
🎯 on BMRN : 0% (2 calls matureds) · 📊 on Health : 50% · -5.0% (6 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Guggenheim ↗
Feb 25, 26
▲ Buy · 🎯$86
Price at call : $61.44 — upside +40%
Today : $65.29 — upside +32%
🎯 on BMRN : 100% (1 call matured) · 📊 on Health : 69.2% · +19.9% (52 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
HC Wainwright & Co. ↗
Feb 25, 26
■ Neutral neutral · not a buy · 🎯$55
Price at call : $61.44 — gap to target -10%
Today : $65.29 — gap to target -16%
🎯 on BMRN : no call matured yet · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Oppenheimer ↗
Feb 24, 26
▲ Outperform · 🎯$95
Price at call : $62.62 — upside +52%
Today : $65.29 — upside +46%
🎯 on BMRN : no call matured yet · 📊 on Health : 53.6% · +4.5% (69 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
Wells Fargo ↗
Feb 18, 26
▲ Overweight · 🎯$75
Price at call : $61.83 — upside +21%
Today : $65.29 — upside +15%
🎯 on BMRN : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Feb 18, 27
matures : Feb 18, 27
Piper Sandler ↗
Feb 6, 26
▲ Overweight · 🎯$84
Price at call : $57.81 — upside +45%
Today : $65.29 — upside +29%
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Canaccord Genuity ↗
Jan 20, 26
▲ Buy · 🎯$98
Price at call : $56.31 — upside +74%
Today : $65.29 — upside +50%
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : Jan 20, 27
matures : Jan 20, 27
Truist Securities ↗
Dec 23, 25
▲ Buy · 🎯$100
Price at call : $61.14 — upside +64%
Today : $65.29 — upside +53%
🎯 on BMRN : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Dec 23, 26
matures : Dec 23, 26
HC Wainwright & Co. ↗
Dec 22, 25
■ Neutral neutral · not a buy · 🎯$60
Price at call : $59.28 — gap to target +1%
Today : $65.29 — gap to target -8%
🎯 on BMRN : no call matured yet · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Dec 22, 26
matures : Dec 22, 26
Leerink Partners ↗
Dec 3, 25
■ Market Perform neutral · not a buy · 🎯$60
Price at call : $54.31 — gap to target +10%
Today : $65.29 — gap to target -8%
🎯 on BMRN : no call matured yet · 📊 on Health : 54.5% · +10.0% (11 calls)
in progress (365j)
matures : Dec 3, 26
matures : Dec 3, 26
■ Hold neutral · not a buy · 🎯$61
Price at call : $51.84 — gap to target +18%
Today : $65.29 — gap to target -7%
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
Freedom Broker
Nov 3, 25
▲ Buy · 🎯$100
Price at call : $52.52 — upside +90%
Today : $65.29 — upside +53%
🎯 on BMRN : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 3, 26
matures : Nov 3, 26
▲ Outperform · 🎯$88
Price at call : $52.85 — upside +67%
Today : $65.29 — upside +35%
🎯 on BMRN : 0% (2 calls matureds) · 📊 on Health : 50% · -5.0% (6 calls)
in progress (365j)
matures : Nov 3, 26
matures : Nov 3, 26
Truist Securities ↗
Oct 28, 25
▲ Buy · 🎯$80
Price at call : $51.86 — upside +54%
Today : $65.29 — upside +23%
🎯 on BMRN : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Oct 28, 26
matures : Oct 28, 26
Wells Fargo ↗
Oct 28, 25
▲ Overweight · 🎯$70
Price at call : $51.86 — upside +35%
Today : $65.29 — upside +7%
🎯 on BMRN : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Oct 28, 26
matures : Oct 28, 26
▲ Buy · 🎯$73
Price at call : $51.86 — upside +41%
Today : $65.29 — upside +12%
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
in progress (365j)
matures : Oct 28, 26
matures : Oct 28, 26
▲ Overweight · 🎯$80
Price at call : $53.49 — upside +50%
Today : $65.29 — upside +23%
🎯 on BMRN : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Oct 28, 26
matures : Oct 28, 26
Morgan Stanley ↗
Oct 28, 25
▲ Overweight · 🎯$98
Price at call : $53.49 — upside +83%
Today : $65.29 — upside +50%
🎯 on BMRN : 0% (1 call matured) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Oct 28, 26
matures : Oct 28, 26
HC Wainwright & Co. ↗
Oct 27, 25
■ Neutral neutral · not a buy · 🎯$55
Price at call : $52.67 — gap to target +4%
Today : $65.29 — gap to target -16%
🎯 on BMRN : no call matured yet · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Oct 27, 26
matures : Oct 27, 26
▲ Overweight · 🎯$119
Price at call : $53.85 — upside +121%
Today : $65.29 — upside +82%
🎯 on BMRN : 100% (1 call matured) · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Oct 9, 26
matures : Oct 9, 26
HC Wainwright & Co. ↗
Sep 8, 25
■ Neutral neutral · not a buy · 🎯$60
Price at call : $56.38 — gap to target +6%
Today : $65.29 — gap to target -8%
🎯 on BMRN : no call matured yet · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Sep 8, 26
matures : Sep 8, 26
Guggenheim ↗
Aug 6, 25
▲ Buy · 🎯$106
Price at call : $59.46 — upside +78%
Today : $65.29 — upside +62%
Expected +78% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 100% (1 call matured) · 📊 on Health : 69.2% · +19.9% (52 calls)
+7.3%
stock +7% · XLV +28%
matured Aug 6, 26
▲ Buy · 🎯$114
Price at call : $61.93 — upside +84%
Today : $65.29 — upside +75%
Expected +84% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 56% (9 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
-3.3%
stock -3% · XLV +24%
matured Aug 5, 26
Morgan Stanley ↗
Jul 22, 25
▲ Overweight · 🎯$96
Price at call : $59.2 — upside +62%
Today : $65.29 — upside +47%
Expected +62% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (1 call matured) · 📊 on Health : 41.3% · -1.5% (196 calls)
-1.4%
stock -1% · XLV +19%
matured Jul 22, 26
▲ Overweight · 🎯$113
Price at call : $56.62 — upside +100%
Today : $65.29 — upside +73%
Expected +100% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 100% (1 call matured) · 📊 on Health : 49.3% · +6.2% (142 calls)
+4.1%
stock +4% · XLV +19%
matured Jul 14, 26
Cantor Fitzgerald ↗
Feb 20, 25
▲ Overweight · 🎯$90
Price at call : $68.25 — upside +32%
Today : $65.29 — upside +38%
Expected +32% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-7.8%
stock -8% · XLV +8%
matured Feb 20, 26
▲ Buy · 🎯$113
Price at call : $68.25 — upside +66%
Today : $65.29 — upside +73%
Expected +66% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 56% (9 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
-7.8%
stock -8% · XLV +8%
matured Feb 20, 26
Piper Sandler ↗
Feb 20, 25
▲ Overweight · 🎯$126
Price at call : $68.73 — upside +83%
Today : $65.29 — upside +93%
Expected +83% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-6.8%
stock -7% · XLV +7%
matured Feb 20, 26
Cantor Fitzgerald ↗
Dec 12, 24
▲ Overweight · 🎯$90
Price at call : $66.01 — upside +36%
Today : $65.29 — upside +38%
Expected +36% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-21.0%
stock -21% · XLV +11%
matured Dec 12, 25
Cantor Fitzgerald ↗
Oct 30, 24
▲ Overweight · 🎯$90
Price at call : $65.89 — upside +37%
Today : $65.29 — upside +38%
Expected +37% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-18.7%
stock -19% · XLV -2%
matured Oct 30, 25
▲ Buy · 🎯$106
Price at call : $65.89 — upside +61%
Today : $65.29 — upside +62%
Expected +61% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 56% (9 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
-18.7%
stock -19% · XLV -2%
matured Oct 30, 25
William Blair ↗
Oct 30, 24
■ Market Perform neutral · not a buy
🎯 on BMRN : no call matured yet · 📊 on Health : 50% · +37.8% (20 calls)
in progress (365j)
matures : Oct 30, 25
matures : Oct 30, 25
▲ Buy · 🎯$87
Price at call : $70.55 — upside +23%
Today : $65.29 — upside +33%
Expected +23% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
-22.9%
stock -23% · XLV -12%
matured Sep 17, 25
▲ Outperform · 🎯$90
Price at call : $70.55 — upside +28%
Today : $65.29 — upside +38%
Expected +28% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (2 calls matureds) · 📊 on Health : 50% · -5.0% (6 calls)
-22.9%
stock -23% · XLV -12%
matured Sep 17, 25
Cantor Fitzgerald ↗
Sep 9, 24
▲ Overweight · 🎯$110
Price at call : $84.85 — upside +30%
Today : $65.29 — upside +68%
Expected +30% · Actual -36% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-35.8%
stock -36% · XLV -12%
matured Sep 9, 25
Piper Sandler ↗
Sep 5, 24
▲ Overweight · 🎯$122
Price at call : $84.08 — upside +45%
Today : $65.29 — upside +87%
Expected +45% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-32.9%
stock -33% · XLV -10%
matured Sep 5, 25
Piper Sandler ↗
Aug 27, 24
▲ Overweight · 🎯$107
Price at call : $90.32 — upside +18%
Today : $65.29 — upside +64%
Expected +18% · Actual -36% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-36.1%
stock -36% · XLV -12%
matured Aug 27, 25
▲ Buy · 🎯$115
Price at call : $90.02 — upside +28%
Today : $65.29 — upside +76%
Expected +28% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
-34.9%
stock -35% · XLV -11%
matured Aug 21, 25
▲ Outperform · 🎯$110
Price at call : $93.84 — upside +17%
Today : $65.29 — upside +68%
Expected +17% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (2 calls matureds) · 📊 on Health : 50% · -5.0% (6 calls)
-38.2%
stock -38% · XLV -11%
matured Aug 20, 25
▲ Buy · 🎯$112
Price at call : $86.87 — upside +29%
Today : $65.29 — upside +72%
Expected +29% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
-30.2%
stock -30% · XLV -12%
matured Aug 6, 25
Cantor Fitzgerald ↗
Aug 5, 24
▲ Overweight · 🎯$110
Price at call : $86.87 — upside +27%
Today : $65.29 — upside +68%
Expected +27% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-30.2%
stock -30% · XLV -12%
matured Aug 5, 25
Cantor Fitzgerald ↗
Jul 22, 24
▲ Overweight · 🎯$110
Price at call : $84.43 — upside +30%
Today : $65.29 — upside +68%
Expected +30% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-29.3%
stock -29% · XLV -8%
matured Jul 22, 25
Cantor Fitzgerald ↗
Apr 25, 24
▲ Overweight · 🎯$110
Price at call : $80.91 — upside +36%
Today : $65.29 — upside +68%
Expected +36% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-22.2%
stock -22% · XLV -1%
matured Apr 25, 25
Piper Sandler ↗
Feb 23, 24
▲ Overweight · 🎯$107
Price at call : $90.1 — upside +19%
Today : $65.29 — upside +64%
Expected +19% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-23.4%
stock -23% · XLV +0%
matured Feb 22, 25
Cantor Fitzgerald ↗
Feb 23, 24
▲ Overweight · 🎯$100
Price at call : $90.1 — upside +11%
Today : $65.29 — upside +53%
Expected +11% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-23.4%
stock -23% · XLV +0%
matured Feb 22, 25
▲ Buy · 🎯$101
Price at call : $96.21 — upside +5%
Today : $65.29 — upside +55%
Expected +5% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
-31.1%
stock -31% · XLV +3%
matured Dec 20, 24
Piper Sandler ↗
Nov 2, 23
▲ Overweight · 🎯$115
Price at call : $79.59 — upside +44%
Today : $65.29 — upside +76%
Expected +44% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-17.1%
stock -17% · XLV +15%
matured Nov 1, 24
Cantor Fitzgerald ↗
Nov 2, 23
▲ Overweight · 🎯$100
Price at call : $79.59 — upside +26%
Today : $65.29 — upside +53%
Expected +26% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-17.1%
stock -17% · XLV +15%
matured Nov 1, 24
Cantor Fitzgerald ↗
Oct 16, 23
▲ Overweight · 🎯$120
Price at call : $86.67 — upside +38%
Today : $65.29 — upside +84%
Expected +38% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-19.1%
stock -19% · XLV +17%
matured Oct 15, 24
▲ Buy · 🎯$120
Price at call : $88.6 — upside +35%
Today : $65.29 — upside +84%
Expected +35% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 56% (9 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
-20.4%
stock -20% · XLV +18%
matured Sep 17, 24
Cantor Fitzgerald ↗
Sep 14, 23
▲ Overweight · 🎯$120
Price at call : $87.68 — upside +37%
Today : $65.29 — upside +84%
Expected +37% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-3.2%
stock -3% · XLV +17%
matured Sep 13, 24
Cantor Fitzgerald ↗
Sep 13, 23
▲ Overweight · 🎯$120
Price at call : $91.62 — upside +31%
Today : $65.29 — upside +84%
Expected +31% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 0% (12 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-7.9%
stock -8% · XLV +17%
matured Sep 12, 24
▲ Buy · 🎯$108
Price at call : $88.39 — upside +22%
Today : $65.29 — upside +65%
Expected +22% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
-4.3%
stock -4% · XLV +13%
matured Jul 31, 24
Piper Sandler ↗
Apr 27, 23
▲ Overweight · 🎯$125
Price at call : $96.04 — upside +30%
Today : $65.29 — upside +91%
Expected +30% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-14.5%
stock -14% · XLV +5%
matured Apr 26, 24
▲ Buy · 🎯$118
Price at call : $100.99 — upside +17%
Today : $65.29 — upside +81%
Expected +17% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
-14.6%
stock -15% · XLV +14%
matured Feb 28, 24
▲ Buy · 🎯$120
Price at call : $97.12 — upside +24%
Today : $65.29 — upside +84%
Expected +24% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 45% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
-7.6%
stock -8% · XLV -4%
matured Nov 29, 23
Piper Sandler ↗
Aug 9, 22
▲ Overweight · 🎯$128
Price at call : $95.7 — upside +34%
Today : $65.29 — upside +96%
Expected +34% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-2.6%
stock -3% · XLV +3%
matured Aug 9, 23
Piper Sandler ↗
Feb 24, 22
▲ Overweight · 🎯$125
Price at call : $77.35 — upside +62%
Today : $65.29 — upside +91%
Expected +62% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+32.0%
stock +32% · XLV +1%
matured Feb 24, 23
▲ Buy · 🎯$96
Price at call : $80.11 — upside +20%
Today : $65.29 — upside +47%
Expected +20% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
+16.0%
stock +16% · XLV -3%
matured Sep 9, 22
Canaccord Genuity ↗
Mar 1, 21
▲ Buy · 🎯$91
Price at call : $77.91 — upside +17%
Today : $65.29 — upside +39%
Expected +17% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+0.3%
stock +0% · XLV +15%
matured Mar 1, 22
Canaccord Genuity ↗
Aug 20, 20
▲ Buy · 🎯$95
Price at call : $75.03 — upside +27%
Today : $65.29 — upside +46%
Expected +27% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+0.6%
stock +1% · XLV +27%
matured Aug 20, 21
Canaccord Genuity ↗
Oct 28, 19
▲ Buy · 🎯$108
Price at call : $72.15 — upside +50%
Today : $65.29 — upside +65%
Expected +50% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+5.6%
stock +6% · XLV +14%
matured Oct 27, 20
Canaccord Genuity ↗
Oct 23, 18
▲ Buy · 🎯$116
Price at call : $92.88 — upside +25%
Today : $65.29 — upside +78%
Expected +25% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
-25.2%
stock -25% · XLV +5%
matured Oct 23, 19
▲ Buy · 🎯$109
Price at call : $99.47 — upside +10%
Today : $65.29 — upside +67%
Expected +10% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
-23.6%
stock -24% · XLV -1%
matured Aug 3, 19
Canaccord Genuity ↗
Jul 31, 18
▲ Buy · 🎯$113
Price at call : $100.56 — upside +12%
Today : $65.29 — upside +73%
Expected +12% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
-21.1%
stock -21% · XLV +2%
matured Jul 31, 19
Canaccord Genuity ↗
May 25, 18
▲ Buy · 🎯$105
Price at call : $92.49 — upside +14%
Today : $65.29 — upside +61%
Expected +14% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
-8.6%
stock -9% · XLV +6%
matured May 25, 19
Canaccord Genuity ↗
May 16, 18
▲ Buy · 🎯$101
Price at call : $89.52 — upside +13%
Today : $65.29 — upside +55%
Expected +13% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+0.2%
stock +0% · XLV +7%
matured May 16, 19
▲ Buy · 🎯$102
Price at call : $84.04 — upside +21%
Today : $65.29 — upside +56%
Expected +21% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
+8.7%
stock +9% · XLV +7%
matured Feb 23, 19
▲ Buy · 🎯$105
Price at call : $83.15 — upside +26%
Today : $65.29 — upside +61%
Expected +26% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
+12.8%
stock +13% · XLV +7%
matured Oct 27, 18
▲ Buy · 🎯$113
Price at call : $99.02 — upside +14%
Today : $65.29 — upside +73%
Expected +14% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
-10.1%
stock -10% · XLV +7%
matured Aug 5, 17
▲ Buy · 🎯$120
Price at call : $99.02 — upside +21%
Today : $65.29 — upside +84%
Expected +21% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 45% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
-10.1%
stock -10% · XLV +7%
matured Aug 5, 17
▲ Buy · 🎯$116
Price at call : $85.21 — upside +36%
Today : $65.29 — upside +78%
Expected +36% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 45% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+3.5%
stock +4% · XLV +7%
matured Apr 8, 17
▲ Buy · 🎯$107
Price at call : $86.67 — upside +23%
Today : $65.29 — upside +64%
Expected +23% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 33% (12 calls matureds) · 📊 on Health : 48% · +12.4% (98 calls)
+6.0%
stock +6% · XLV +12%
matured Mar 3, 17
▲ Buy · 🎯$166
Price at call : $128.1 — upside +30%
Today : $65.29 — upside +154%
Expected +30% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 45% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
-25.9%
stock -26% · XLV +3%
matured Aug 24, 16
Piper Sandler ↗
Aug 4, 15
▲ Overweight · 🎯$168
Price at call : $143.66 — upside +17%
Today : $65.29 — upside +157%
Expected +17% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-30.7%
stock -31% · XLV -3%
matured Aug 3, 16
▲ Buy · 🎯$156
Price at call : $138.66 — upside +13%
Today : $65.29 — upside +139%
Expected +13% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 45% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
-39.5%
stock -40% · XLV -8%
matured Jun 17, 16
Piper Sandler ↗
Jun 18, 15
▲ Overweight · 🎯$147
Price at call : $138.66 — upside +6%
Today : $65.29 — upside +125%
Expected +6% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-39.5%
stock -40% · XLV -8%
matured Jun 17, 16
▲ Buy · 🎯$135
Price at call : $123.52 — upside +9%
Today : $65.29 — upside +107%
Expected +9% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 45% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
-30.4%
stock -30% · XLV -5%
matured Mar 12, 16
▲ Buy · 🎯$112
Price at call : $92.9 — upside +21%
Today : $65.29 — upside +72%
Expected +21% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 56% (9 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+1.0%
stock +1% · XLV +1%
matured Dec 11, 15
▲ Buy · 🎯$100
Price at call : $89.45 — upside +12%
Today : $65.29 — upside +53%
Expected +12% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 45% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+7.4%
stock +7% · XLV +5%
matured Nov 25, 15
▲ Buy · 🎯$74
Price at call : $61.78 — upside +20%
Today : $65.29 — upside +13%
Expected +20% · Actual +98% · Reason (≥ +15%) : ✓ Yes
🎯 on BMRN : 56% (9 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+97.5%
stock +98% · XLV +25%
matured Jun 11, 15
▲ Buy · 🎯$73
Price at call : $58.23 — upside +25%
Today : $65.29 — upside +12%
Expected +25% · Actual +92% · Reason (≥ +15%) : ✓ Yes
🎯 on BMRN : 56% (9 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+92.4%
stock +92% · XLV +23%
matured Apr 30, 15
▲ Buy · 🎯$86
Price at call : $77.49 — upside +11%
Today : $65.29 — upside +32%
Expected +11% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 45% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
-10.2%
stock -10% · XLV +25%
matured Sep 18, 14
Canaccord Genuity ↗
Sep 5, 13
▲ Buy · 🎯$85
Price at call : $72.7 — upside +17%
Today : $65.29 — upside +30%
Expected +17% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
-4.8%
stock -5% · XLV +28%
matured Sep 5, 14
Piper Sandler ↗
Mar 20, 13
▲ Overweight · 🎯$70
Price at call : $61.08 — upside +15%
Today : $65.29 — upside +7%
Expected +15% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+28.6%
stock +29% · XLV +33%
matured Mar 20, 14
Piper Sandler ↗
Feb 19, 13
▲ Overweight · 🎯$64
Price at call : $55.17 — upside +16%
Today : $65.29 — upside -2%
Expected +16% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on BMRN : 25% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+45.2%
stock +45% · XLV +36%
matured Feb 19, 14
▲ Buy · 🎯$65
Price at call : $56.51 — upside +15%
Today : $65.29 — upside -0%
Expected +15% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on BMRN : 45% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+35.1%
stock +35% · XLV +34%
matured Feb 19, 14
Canaccord Genuity ↗
Feb 12, 13
▲ Buy · 🎯$71
Price at call : $54.82 — upside +30%
Today : $65.29 — upside +9%
Expected +30% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+33.2%
stock +33% · XLV +33%
matured Feb 12, 14
▲ Buy · 🎯$67
Price at call : $55.6 — upside +21%
Today : $65.29 — upside +3%
Expected +21% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on BMRN : 56% (9 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+20.8%
stock +21% · XLV +28%
matured Feb 1, 14
▲ Buy · 🎯$46
Price at call : $40.75 — upside +13%
Today : $65.29 — upside -30%
Expected +13% · Actual +81% · Reason (≥ +15%) : ✓ Yes
🎯 on BMRN : 45% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+80.9%
stock +81% · XLV +24%
matured Oct 3, 13
▲ Buy · 🎯$44
Price at call : $37.24 — upside +18%
Today : $65.29 — upside -33%
Expected +18% · Actual +73% · Reason (≥ +15%) : ✓ Yes
🎯 on BMRN : 45% (11 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+73.1%
stock +73% · XLV +35%
matured Aug 2, 13
▲ Buy · 🎯$43
Price at call : $32.74 — upside +31%
Today : $65.29 — upside -34%
Expected +31% · Actual +93% · Reason (≥ +15%) : ✓ Yes
🎯 on BMRN : 56% (9 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+93.1%
stock +93% · XLV +29%
matured Apr 12, 13
Canaccord Genuity ↗
Mar 26, 12
▲ Buy · 🎯$43
Price at call : $35.22 — upside +22%
Today : $65.29 — upside -34%
Expected +22% · Actual +72% · Reason (≥ +15%) : ✓ Yes
🎯 on BMRN : 60% (10 calls matureds) · 📊 on Health : 53.3% · +6.6% (92 calls)
+72.1%
stock +72% · XLV +22%
matured Mar 26, 13
Frequently asked questions
Should I buy BioMarin Pharmaceutical stock?
This isn't buy advice. For BioMarin Pharmaceutical, the analyst consensus is "Buy", with an average price target of $97.00 (+49% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on BioMarin Pharmaceutical). We show the numbers — you decide.
Is it too late to buy BioMarin Pharmaceutical? How high can it go?
The most bullish analyst target on BioMarin Pharmaceutical is $124 (+90% above today's price); the average is $97.00. That's the upside they see. Check how reliable those analysts have actually been on BioMarin Pharmaceutical on our site before trusting it.
Is BioMarin Pharmaceutical still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 29 analysts have a real record on BioMarin Pharmaceutical, the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in BioMarin Pharmaceutical? The case for and against
The arguments for and against, one by one, from the numbers: why invest in BMRN (and why hesitate).
What has BioMarin Pharmaceutical's past performance been?
Historical returns and a "how much if I had invested" calculator: BMRN performance & returns.
What is the best month to buy BMRN?
The 12 months ranked by the stock's past returns: best & worst month to buy BMRN.
Are insiders buying BMRN stock?
Executives' and large holders' buys and sells, decoded: insider buying on BMRN.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX